Clinical Investigator Information
Conducting a Clinical Investigation
- Clinical Trials and Human Subject Protection
FDA's Office of Science and Research - Clinical Trials Guidance Documents
- Participation of Females in Clinical Trials and Gender Analysis of Data in Biologic Product Applications - ARCHIVED
A research study funded by the FDA Office of Women's Health - Section 8200: Investigational New Drugs (INDs)
Standard Operating Policies and Procedures (CBER) - Clinical Hold / Refusal to File Meetings
Compliance, Enforcement, Investigations
- Compliance Actions (Biologics)
- Letters to Industry / Healthcare Providers / Clinical Investigators - ARCHIVED
Rules
- Expanded Access to Investigational Drugs for Treatment Use, Final Rule (Federal Register)
- Charging for Investigational Drugs Under an Investigational New Drug Application, Final Rule (Federal Register)